Loviride

• CAT Number: M093940
• CAS Number: 147362-57-0
• Molecular Formula: C17H16Cl2N2O2
• Molecular Weight: 351.23
• Purity: ≥95%
• Synonyms: Loviride
• Target: Reverse Transcriptase
• Storage: Desiccate at +4C
• IUPAC Name: 2-(2-acetyl-5-methylanilino)-2-(2,6-dichlorophenyl)acetamide
• InChI: InChI=1S/C17H16Cl2N2O2/c1-9-6-7-11(10(2)22)14(8-9)21-16(17(20)23)15-12(18)4-3-5-13(15)19/h3-8,16,21H,1-2H3,(H2,20,23)
• InChIKey: CJPLEFFCVDQQFZ-UHFFFAOYSA-N
• SMILES: CC1=CC(=C(C=C1)C(=O)C)NC(C2=C(C=CC=C2Cl)Cl)C(=O)N

Loviride（Cat No.:M093940）is a non-nucleoside reverse transcriptase inhibitor (NNRTI) developed for the treatment of HIV-1 infections. It binds to reverse transcriptase, causing conformational changes that inhibit the enzyme’s function, thereby preventing viral RNA replication. Loviride has demonstrated antiviral activity and was explored as a potential addition to combination therapies for managing HIV. Although no longer widely used clinically, it remains a valuable compound in HIV research for studying NNRTI mechanisms, resistance patterns, and the development of next-generation therapies aimed at improving antiretroviral treatment outcomes.